How to request Lovenox through the Ontario Exceptional Access Program — and autofill it with my-id.ca
Request Lovenox through the EAP — fill the patient section fast
An EAP request for Lovenox has a patient section and a physician section. This guide is an example of letting my-id.ca fill the patient part.
Official form and source
- Service page: Get coverage for prescription drugs — ontario.ca
- Form (Central Forms Repository): EAP Request Lovenox (Enoxaparin) — 014-4943-87
What this form is about
The request asks the Exceptional Access Program to approve funding for Lovenox when the criteria are met. The physician provides the clinical justification.
Before you start: what to gather (patient section)
- The patient's name and Ontario health number.
- The prescribing physician to complete the clinical section.
How my-id.ca makes it faster
- Store the patient details once. Save the name and health number in my-id.ca.
- Autofill the patient section. Use the my-id.ca Chrome extension on a web form, or fill a PDF from the saved profile inside my-id.ca.
- Physician completes the clinical part.
- Submit to the EAP.
Why do it in my-id.ca
The same patient details appear on every EAP form. Stored once in my-id.ca — in Canada, with self-hosted AI — the patient section fills itself.
Frequently asked questions
- What does the EAP Lovenox request ask for?
- The patient's name, Ontario health number, and clinical information completed by the prescribing physician. my-id.ca can store the patient details for autofill.
- Can my-id.ca complete the physician section?
- No — that requires the prescribing physician. my-id.ca only autofills the patient details.
- Where is it submitted?
- To the Ministry of Health's Exceptional Access Program. Confirm the current process on ontario.ca.
Fill it once. Reuse it everywhere.
Save your information in my-id.ca once, then autofill this form and the next one — web forms with the Chrome extension, PDFs right in the app. Your data is stored in Canada and AI runs on my-id.ca's own servers, never sent to third-party AI providers.